Colony Group LLC Eli Lilly & CO Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Colony Group LLC holds 29,460 shares of LLY stock, worth $23.4 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

29,460

Previous 32,065 8.12%

Holding current value

$23.4 Million

Previous $15 Million 5.23%

% of portfolio

0.24%

Previous 0.21%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $1.13 Million - $1.56 Million	-2,605 Reduced 8.12%	29,460 $15.8 Million
Q2 2023 Aug 15, 2023	BUY	$350.74 - $468.98 $498,050 - $665,951	1,420 Added 4.63%	32,065 $15 Million
Q1 2023 May 16, 2023	SELL	$310.63 - $364.82 $852,679 - $1 Million	-2,745 Reduced 8.22%	30,645 $10.5 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $383,609 - $446,981	1,193 Added 3.71%	33,390 $12.2 Million
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $461,619 - $526,063	-1,557 Reduced 4.61%	32,197 $10.4 Million
Q2 2022 Aug 16, 2022	BUY	$278.73 - $327.27 $4.13 Million - $4.85 Million	14,829 Added 78.36%	33,754 $10.9 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $2.45 Million - $3.04 Million	10,423 Added 122.59%	18,925 $5.42 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $195,844 - $243,043	871 Added 11.41%	8,502 $2.35 Million
Q3 2021 Nov 17, 2021	BUY	$221.6 - $272.71 $112,351 - $138,263	507 Added 7.12%	7,631 $1.76 Million
Q2 2021 Aug 18, 2021	BUY	$180.55 - $233.54 $58,498 - $75,666	324 Added 4.76%	7,124 $1.64 Million
Q1 2021 May 21, 2021	BUY	$164.32 - $212.72 $151,010 - $195,489	919 Added 15.63%	6,800 $1.27 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $174,425 - $230,806	1,337 Added 29.42%	5,881 $993,000
Q3 2020 Nov 17, 2020	BUY	$146.22 - $169.13 $19,447 - $22,494	133 Added 3.02%	4,544 $673,000
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $633,125 - $761,959	-4,641 Reduced 51.27%	4,411 $724,000
Q1 2020 May 18, 2020	BUY	$119.05 - $147.35 $723,943 - $896,035	6,081 Added 204.68%	9,052 $1.26 Million
Q4 2019 Feb 18, 2020	BUY	$106.92 - $132.43 $38,384 - $47,542	359 Added 13.74%	2,971 $390,000
Q3 2019 Nov 26, 2019	SELL	$106.79 - $116.16 $467,846 - $508,896	-4,381 Reduced 62.65%	2,612 $292,000
Q2 2019 Aug 19, 2019	BUY	$110.79 - $129.32 $78,771 - $91,946	711 Added 11.32%	6,993 $775,000
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $699,249 - $823,067	6,282 New	6,282 $815,000
Q2 2018 Aug 15, 2018	SELL	$75.7 - $86.88 $207,872 - $238,572	-2,746 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $29,980 - $35,390	-404 Reduced 12.83%	2,746 $212,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $258,111 - $276,853	3,150	3,150 $266,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account